Multipotential marrow stromal cells transduced to produce L-DOPA: Engraftment in a rat model of Parkinson disease

Human Gene Therapy

Volumn 10, Issue 15, 1999, Pages 2539-2549

  Schwarz, Emily J ^a   Alexander, Guillermo M ^a   Prockop, Darwin J ^a   Azizi, S A ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA; TETRAHYDROBIOPTERIN; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL SURVIVAL; CONTROLLED STUDY; DENERVATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; LIPID METABOLISM; NONHUMAN; PARKINSON DISEASE; RAT; STROMA CELL; TRANSACTIVATION; TRANSGENE;

ANIMALS; BONE MARROW CELLS; BRAIN; CELL SURVIVAL; CELL TRANSPLANTATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GENE THERAPY; GTP CYCLOHYDROLASE; HUMANS; IMMUNOHISTOCHEMISTRY; LEVODOPA; MALE; PARKINSON DISEASE; RATS; RATS, INBRED LEW; STROMAL CELLS; TRANSDUCTION, GENETIC; TYROSINE 3-MONOOXYGENASE;

ANIMALIA;

EID: 0033544028     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950016870     Document Type: Article

References (41)

1. ABERCROMBIE, E.D., BONATZ, A.E., and ZIGMOND, H.J. (1990). Effects on extracellular dopamine in striatum of normal and 6-hydroxydopamine treated rats. Brain Res. 525, 36-44.
2. AZIZI, S.A., STOKES, D., AUGELLI, B.J., DIGIROLAMO, C., and PROCKOP, D.J. (1998). Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats-similarities to astrocyte grafts. Proc. Natl. Acad. Sci. U.S.A. 95, 3908-3913.
3. BENCSICS, C., WACHTEL, S.R., MILSTIEN, S., HATAKEYAMA, K., BECKER, J.B., and KANG, U.J. (1996). Double transduction with GTP cyclohydrolase I and tyrosine hydroxylase is necessary for spontaneous synthesis of L-DOPA by primary fibroblasts. J. Neurosci. 16, 4449-4456.
4. BJORKLUND, A. (1993). Neurobiology. Better cells for brain repair. Nature (London) 362, 414-415.
5. BOHIC, S., PILET, P., and HEYMANN, D. (1998). Effects of leukemia inhibitory factor and oncostatin M on bone mineral formed in in vitro rat bone-marrow stromal cell culture: physicochemical aspects. Biochem. Biophys. Res. Commun. 253, 506-513.
6. BOHN, M.C., CUPIT, L., MARCIANO, F., and GASH, D.M. (1987). Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers. Science 237, 913-916.
7. BROOK, G.A., LAWRENCE, J.M., SHAH, B., and RAISMAN, G. (1994). Extrusion transplantation of Schwann cells into the adult rat thalamus induces directional host axon growth. Exp. Neurol. 126, 31-13.
8. BRUDER, S.P., JAISWAL, N., and HAYNESWORTH, S.E. (1997). Growth kinetics, self-renewal, and the osteogenic potential or purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J. Cell. Biochem. 64, 278-294.
9. CAPLAN, A.I. (1991). Mesenchymal stem cells. J. Orthoped. Res. 9, 641-650.
10. CHASE, T.N., BARONTI, F., FABBRINI, G., HEUSER, I.J., JUNCOS, J.L., and MOURADIAN, M.M. (1989). Rationale for continuous dopaminomimetic therapy of Parkinson's disease. Neurology 39(11,Suppl. 2), 7-10.
11. CHASE, T.N., MOURADIAN, M.M., and ENGBER, T.M. (1993). Motor response complications and the functions of striatal efferent systems. Neurology 43(12, Suppl. 6), S23-S27.
12. DUNNETT, S.B., HERNANDEZ, T.D., SUMMERFIELD, A., JONES, G.H., and ARBUTHNOTT, G. (1988). Graft-derived recovery from 6-OHDA lesions: Specificity of ventral mesencephalic graft tissues. Exp. Brain Res. 71(2), 411-424.
13. DURING, M.J., NAEGELE, J.R., O'MALLEY, K.L., and GELLER, A.I. (1994). Long-term behavioral recovery in Parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science 266, 1399-1403.
14. DURING, M.J., SAMULSKI, R.J., ELSWORTH, J.D., KAPLITT, M.G., LEONE, P., XIAO, X., LI, J., FREESE, A., TAYLOR, J.R., ROTH, R.H., SLADEK, J.R., JR., O'MALLEY, K.L., and REDMONO, D.E., JR. (1998). In vivo expression of therapeutic human genes for dopamine production in the caudales of MPTP-treated monkeys using an AAV vector. Gene Ther. 5, 820-827.
15. EGLITIS, M.A., and MEZEY, E. (1997). Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc. Natl. Acad. Sci. U.S.A. 94(8), 4080-4085.
16. FAN, D.-S., OGAWA, M., FUJIMOTO, K.-I., IKEGUCHI, K., OGASAWARA, Y., URABE, M., NISHIZAWA, M., NAKANO, I., YOSHIDA, M., NAGATSU, I., ICHINOSE, H., NAGATSU, T., KURTZMAN, G.J., and OZAWA, K. (1998). Behavioral recovery in 6-hydroxydopamine-lesioned rats by cotransduction of striatum with tyrosine hydroxylase and aromatic L-amino acid decarboxylase genes using two separate adeno-associated virus vectors. Hum. Gene Ther. 9, 2527-2535.
17. HAUSER, R.A., FREEMAN, T.B., SNOW, B.J., NAUERT, M., GAUGER, L., KORDOWER, J.H., and OLANOW, C.W. (1999). Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease. Arch. Neurol. 56, 179-187.
18. HORRELLOU, P., BRUNDIN, P., KALEN, P., MALLET, J., and BJORKLAND, A. (1990). In vivo release of DOPA and dopamine from genetically engineered cells grafted to the denervated striatum. Neuron 5, 393-402.
19. KANG, U.J., FISHER, L.J., JOH, T.H., O'MALLEY, K.L., and GAGE, F.H. (1993). Regulation of dopamine production by genetically modified primary fibroblasts. J. Neurosci. 13, 5203-5211.
20. KAWAJA, M.D., and GAGE, F.H. (1992). Morphological and neurochemical features of cultured primary skin fibroblasts of Fischer-344 rats following striatal implantation. J. Comp. Neurol. 317, 102-116.
21. KUZNETSOV, S.A., KREBSBACH, P.H., SATOMURA, K., KERR, J., RIMINUCCI, M., BENAYAHU, D., and ROBEY, P.G. (1997). Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J. Bone Miner. Res. 12, 1335-1347.
22. LACHAPELLE, F., DUHAMEL-CLERIN, E., GANSMULLER, A., BARON-VAN EVERCOOREN, A., VILLARROYA, H., and GUMPEL, M. (1994). Transplanted transgenically marked oligodendrocytes survive, migrate and myelinate in the normal mouse brain as they do in the shiverer mouse brain. Eur. J. Neurosci. 6, 814-824.
23. LEVINE, R.A., MILLER, L.P., and LOVENBERG, W. (1981). Tetrahydrobiopterin in striatum: Localization in dopamine nerve terminals and role in catecholamine synthesis. Science 213, 349-350.
24. LJUNGBERG, M.C., STERN, G., and WILKIN, G.P. (1999). Survival of genetically engineered, adult-derived rat astrocytes grafted into the 6-hydroxydopamine lesioned adult rat striatum. Brain Res. 816, 29-37.
25. LOPEZ-LOZANO, J.J., BRAVO, G., BRERA, B., DARGALLO, J., SALMEAN, J., URIA, J., INSAUSTI, J., MARTINEZ, R., SANCHEZ, P., DE LA TORRE, C., and MORENO, R. (1997). Regression of parkinsonian fetal ventral mesencephalon grafts upon withdrawal of cyclosporine A immunosuppression. Transplant. Proc. 29, 977-980.
26. LUNDBERG, C., HORELLOU, P., MALLET, J., and BJORKLUND, A. (1996). Generation of DOPA-producing astrocytes by retroviral transduction of the human tyrosine hydroxylase gene: In vitro characterization and in vivo effects in the rat Parkinson model. Exp. Neurol. 139, 39-53.
27. MANDEL, R.J., RENDAHL, K.G., SPRATT, S.K., SNYDER, R.O., COHEN, L.K., and LEFF, S.E. (1998). Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's disease. J. Neurosci. 18, 4271-4284.
28. MILLER, A.D., and ROSMAN, G.J. (1989). Improved retroviral vectors for gene transfer and expression. BioTechniques 7, 980-989.
29. NALDINI, L., BLOMER, U., GALLAY, P., ORY, D., MULLIGAN, R., GAGE, F.H., VERMA, I., and TRONO, D. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267.
30. OBESO, J.A., GRANDAS, F., HERRERO, M.T., and HOROWSKI, R. (1994). The role of pulsatile versus continuous dopamine receptor stimulation for functional recovery in Parkinson's disease. Eur. J. Neursci. 6(6), 889-897.
31. OLSON, L. (1997). Regeneration in the adult central nervous system: Experimental repair strategies. Nature Med. 3, 1329-1335.
32. OWEN, M.E., and FRIEDENSTEIN, A.J. (1988). Stromal stem cells: Marrow-derived osteogenic precursors. In Cell and Molecular Biology of Vertebrate Hard Tissues. (Ciba Foundation Symp., Chicester, UK) pp. 42-60.
33. PEREIRA, R.F., O'HARA, M.D., LAPTEV, A.V., HALFORD, K.W., POLLARD, M.D., CLASS, R., SIMON, D., LIVEZEY, K., and PROCKOP, D.J. (1998). Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc. Natl. Acad. Sci. U.S.A. 95, 1142-1147.
34. PROCKOP, D.J. (1997). Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276, 71-74.
35. ROSENSTEIN, J.M. (1995). Why do neural transplants survive? An examination of some metabolic and pathophysiological considerations in neural transplantation. Exp. Neurol. 133(1), 1-6.
36. SCHUH, L.A., and BENNETT, J.P., Jr. (1993). Suppression of dyskinesias in advanced Parkinson's disease. I. Continuous intravenous levodopa shifts dose response for production of dyskinesias but not for relief of parkinsonism in patients with advanced Parkinson's disease. Neurology 43(8), 1545-1550.
37. SEGOVIA, J., VERGARA, P., and BRENNER, M. (1998). Astrocyte-specific expression of tyrosine hydroxylase after intracerebral gene transfer induces behavioral recovery in experimental Parkinsonism. Gene Ther. 5, 1650-1655.
38. WACHTEL, S.R., and ABERCROMBIE, E.D. (1994). L-3,4,-Dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: Differential effects of monoamine oxidase A and B inhibitors. J. Neurochem. 63, 108-117.
39. WACHTEL, S.R., BENCSICS, C., and KANG, U.J. (1997). Role of aromatic L-amino acid decarboxylase for dopamine replacement by genetically modified fibroblasts in a rat model of Parkinson's disease. J. Neurochem. 69, 2055-2063.
40. YOO, J.U., BARTHEL, T.S., NISHIMURA, K., SOLCHAGA, L., CAPLAN, A.I., GOLDBERG, V.M., and JOHNSTONE, B. (1998). The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J. Bone Joint Surg. Am. 80, 1745-1757.
41. ZUFFEREY, R., DULL, T., MANDEL, R.J., BUKOVSKY, A., QUIROZ, D., NALDINI, L., and TRONO, D. (1998). Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 72, 9873-9880.